Zonglei Du, W. Bian, Shanxia Wu, Bi-hu Gao, Yanfang Sun, Z. Kang, Xianchao Zhang
{"title":"Effects of blood pressure goals on cardiovascular outcomes in hypertensive patients","authors":"Zonglei Du, W. Bian, Shanxia Wu, Bi-hu Gao, Yanfang Sun, Z. Kang, Xianchao Zhang","doi":"10.5114/aoms.2018.80013","DOIUrl":null,"url":null,"abstract":"Introduction The aim of the study was to evaluate the effects of blood pressure (BP) goals on cardiovascular outcomes in hypertensive patients. Material and methods Primary hypertensive patients were retrospectively enrolled from outpatient clinics. The demographics, comorbidities, laboratory parameters and glomerular filtration rate (GFR) were collected. All participants were followed for 1 year. Cardiovascular outcomes included composite of all-cause mortality, non-fatal myocardial infarction, and non-fatal ischemic stroke/transient ischemic attack. Adverse event was defined as falling down and GFR decrease at follow-up. Results A total of 1226 patients were included. Based on therapeutic BP goals, participants were divided into low (< 130/80 mm Hg) and high (< 140/90 mm Hg) therapeutic goal groups and an uncontrolled hypertension (≥ 140/90 mm Hg) group. Compared to the low therapeutic goal group, patients in the uncontrolled group were older and more likely to be smokers, have longer duration of hypertension, diabetes mellitus, lower GFR and higher prevalent ischemic stroke (p < 0.05). Patients in the uncontrolled hypertension group had higher incidence of composite endpoints than low and high therapeutic goal groups. Two cases of falling down were observed in the low therapeutic goal group and no significant changes in GFR were observed. With adjustment for confounding factors, the uncontrolled hypertension group had higher risk of composite endpoints compared to low and high therapeutic goal groups, and these benefits were more prominent in the low versus high therapeutic goal group. Conclusions In hypertension patients, when compared to uncontrolled hypertension patients, low therapeutic BP goal is associated with better cardiovascular outcomes than high therapeutic BP goal.","PeriodicalId":190584,"journal":{"name":"Archives of Medical Science : AMS","volume":"46 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Medical Science : AMS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/aoms.2018.80013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
Introduction The aim of the study was to evaluate the effects of blood pressure (BP) goals on cardiovascular outcomes in hypertensive patients. Material and methods Primary hypertensive patients were retrospectively enrolled from outpatient clinics. The demographics, comorbidities, laboratory parameters and glomerular filtration rate (GFR) were collected. All participants were followed for 1 year. Cardiovascular outcomes included composite of all-cause mortality, non-fatal myocardial infarction, and non-fatal ischemic stroke/transient ischemic attack. Adverse event was defined as falling down and GFR decrease at follow-up. Results A total of 1226 patients were included. Based on therapeutic BP goals, participants were divided into low (< 130/80 mm Hg) and high (< 140/90 mm Hg) therapeutic goal groups and an uncontrolled hypertension (≥ 140/90 mm Hg) group. Compared to the low therapeutic goal group, patients in the uncontrolled group were older and more likely to be smokers, have longer duration of hypertension, diabetes mellitus, lower GFR and higher prevalent ischemic stroke (p < 0.05). Patients in the uncontrolled hypertension group had higher incidence of composite endpoints than low and high therapeutic goal groups. Two cases of falling down were observed in the low therapeutic goal group and no significant changes in GFR were observed. With adjustment for confounding factors, the uncontrolled hypertension group had higher risk of composite endpoints compared to low and high therapeutic goal groups, and these benefits were more prominent in the low versus high therapeutic goal group. Conclusions In hypertension patients, when compared to uncontrolled hypertension patients, low therapeutic BP goal is associated with better cardiovascular outcomes than high therapeutic BP goal.
本研究的目的是评估血压(BP)目标对高血压患者心血管结局的影响。材料与方法回顾性分析门诊原发性高血压患者。收集统计数据、合并症、实验室参数和肾小球滤过率(GFR)。所有参与者随访1年。心血管结局包括全因死亡率、非致死性心肌梗死和非致死性缺血性卒中/短暂性缺血性发作的综合结果。不良事件定义为随访时跌倒和GFR下降。结果共纳入1226例患者。根据血压治疗目标,参与者被分为低(< 130/80 mm Hg)和高(< 140/90 mm Hg)治疗目标组和未控制的高血压(≥140/90 mm Hg)组。与低治疗目标组相比,对照组患者年龄大,吸烟倾向高,高血压、糖尿病病程长,GFR较低,缺血性脑卒中发生率较高(p < 0.05)。高血压未控制组患者复合终点发生率高于低、高治疗目标组。低治疗目标组2例跌倒,GFR无明显变化。在调整混杂因素后,与低和高治疗目标组相比,未控制的高血压组复合终点的风险更高,并且这些益处在低治疗目标组与高治疗目标组中更为突出。结论在高血压患者中,与未控制的高血压患者相比,较低的血压治疗目标比较高的血压治疗目标有更好的心血管预后。